GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GTBP | SBFM | CELZ | ||
| Company | GT Biopharma Inc | Sunshine Biopharma | Creative Medical Technology Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.4303 | 1.0600 | 1.8800 | ||
| High | 0.4601 | 1.0750 | 1.8844 | ||
| Low | 0.4200 | 1.0400 | 1.8100 | ||
| Latest | 0.4601 | 1.0400 | 1.8400 | ||
| Change | +0.0347 | -0.0500 | -0.0400 | ||
| % Change | +8.16% | -4.59% | -2.13% | ||
| Volume | 1,663,900 | 28,000 | 51,300 | ||
| 20-Day Average Volume | 755,435 | 37,850 | 18,215 | ||
| Previous Close | 0.4254 | 1.0900 | 1.8800 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.4466 | 1.1365 | 1.8655 | ||
| 20-Day Raw Stochastic | 69.64% | 0.00% | 34.62% | ||
| 20-Day Relative Strength | 44.81 | 35.42 | 44.38 | ||
| Weighted Alpha | -85.17 | -57.39 | -34.05 | ||
| Today's Opinion | 88% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.00% since 03/13/26 | -5.45% since 03/13/26 | -2.13% since 03/13/26 | ||
| Low | 0.4042 on 03/16/26 | 1.0400 on 03/20/26 | 1.8100 on 03/20/26 | ||
| High | 0.4601 on 03/20/26 | 1.1494 on 03/18/26 | 1.9700 on 03/16/26 | ||
| 1-Month | |||||
| %Chg | +0.02% since 02/20/26 | -11.86% since 02/20/26 | -3.16% since 02/20/26 | ||
| Low | 0.3915 on 03/11/26 | 1.0400 on 03/20/26 | 1.7500 on 03/04/26 | ||
| High | 0.4900 on 02/27/26 | 1.2500 on 02/26/26 | 2.0100 on 03/12/26 | ||
| 3-Month | |||||
| %Chg | -39.21% since 12/19/25 | -25.18% since 12/19/25 | -12.80% since 12/19/25 | ||
| Low | 0.3915 on 03/11/26 | 1.0400 on 03/20/26 | 1.5040 on 12/29/25 | ||
| High | 0.9440 on 12/30/25 | 1.4300 on 01/08/26 | 2.4999 on 01/06/26 | ||
| 6-Month | |||||
| %Chg | -41.17% since 09/19/25 | -29.25% since 09/19/25 | -47.58% since 09/19/25 | ||
| Low | 0.3915 on 03/11/26 | 1.0400 on 03/20/26 | 1.5040 on 12/29/25 | ||
| High | 1.3700 on 10/08/25 | 2.4300 on 10/16/25 | 6.2500 on 10/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,894 | 5,102 | 4,748 | ||
| Shares Outstanding, K | 10,636 | 4,906 | 2,580 | ||
| Annual Sales | 0 | 34,870,000 | 10,000 | ||
| Annual Net Income | -28,350,000 | -5,130,000 | -5,490,000 | ||
| Last Quarter Sales | 0 | 9,420,000 | 0 | ||
| Last Quarter Net Income | -23,030,000 | -880,000 | -1,240,000 | ||
| 60-Month Beta | 1.28 | 1.51 | 2.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/02/26 | -0.19 on 11/13/25 | -0.48 on 11/07/25 | ||
| Latest Earnings Date | 05/21/26 | 04/07/26 | 03/20/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||